These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


417 related items for PubMed ID: 19153211

  • 1. Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models.
    Festuccia C, Gravina GL, D'Alessandro AM, Muzi P, Millimaggi D, Dolo V, Ricevuto E, Vicentini C, Bologna M.
    Endocr Relat Cancer; 2009 Jun; 16(2):401-13. PubMed ID: 19153211
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ketoconazole potentiates the antitumor effects of nocodazole: In vivo therapy for human tumor xenografts in nude mice.
    Wang YJ, Jeng JH, Chen RJ, Tseng H, Chen LC, Liang YC, Lin CH, Chen CH, Chu JS, Ho WL, Ho YS.
    Mol Carcinog; 2002 Aug; 34(4):199-210. PubMed ID: 12203371
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
    Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH.
    Oncogene; 2001 May 24; 20(23):2927-36. PubMed ID: 11420705
    [Abstract] [Full Text] [Related]

  • 8. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
    Aranha O, Grignon R, Fernandes N, McDonnell TJ, Wood DP, Sarkar FH.
    Int J Oncol; 2003 Apr 24; 22(4):787-94. PubMed ID: 12632069
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic integration of c-myc and bcl-2 antisense molecules with docetaxel in a preclinical model of hormone-refractory prostate cancer.
    Leonetti C, Biroccio A, D'Angelo C, Semple SC, Scarsella M, Zupi G.
    Prostate; 2007 Sep 15; 67(13):1475-85. PubMed ID: 17654511
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators.
    Cerda SR, Mustafi R, Little H, Cohen G, Khare S, Moore C, Majumder P, Bissonnette M.
    Oncogene; 2006 May 25; 25(22):3123-38. PubMed ID: 16434969
    [Abstract] [Full Text] [Related]

  • 14. Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways.
    Zhang YW, Jiang XX, Chen QS, Shi WY, Wang L, Sun HD, Shen ZX, Chen Z, Chen SJ, Zhao WL.
    Exp Hematol; 2010 Mar 25; 38(3):191-201. PubMed ID: 20045442
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells.
    Yoo J, Park SS, Lee YJ.
    J Cell Biochem; 2008 Aug 01; 104(5):1636-46. PubMed ID: 18404675
    [Abstract] [Full Text] [Related]

  • 17. Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.
    Henry JY, Lu L, Adams M, Meyer B, Bartlett JB, Dalgleish AG, Galustian C.
    Prostate; 2012 Jun 01; 72(8):856-67. PubMed ID: 21968939
    [Abstract] [Full Text] [Related]

  • 18. Combined effect of sodium selenite and docetaxel on PC3 metastatic prostate cancer cell line.
    Freitas M, Alves V, Sarmento-Ribeiro AB, Mota-Pinto A.
    Biochem Biophys Res Commun; 2011 May 20; 408(4):713-9. PubMed ID: 21549092
    [Abstract] [Full Text] [Related]

  • 19. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
    Singh RP, Deep G, Blouin MJ, Pollak MN, Agarwal R.
    Carcinogenesis; 2007 Dec 20; 28(12):2567-74. PubMed ID: 17916909
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models.
    Gravina GL, Marampon F, Giusti I, Carosa E, Di Sante S, Ricevuto E, Dolo V, Tombolini V, Jannini EA, Festuccia C.
    Int J Oncol; 2012 Mar 20; 40(3):711-20. PubMed ID: 22134754
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.